Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

Author

Xu Huang

View on Semantic Scholar

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

P1.074. SNORD33-Driven 18S rRNA 2′-O-Methylation Licenses TNFSF9–4-1BB Signaling and Sensitizes ESCC to PD-1 Blockade

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant PD-1/PD-L1 based immunotherapy improve outcomes for resectable esophageal squamous cell carcinoma (ESCC), but patient outcome are heterogeneous and robust pretreatment blood biomarkers are lacking. We performed an unbiased plasma sno...

Runze You, Xu Huang, Lijie Tan · 0 citations
Open access Aug 2026

P1.057. Early Recurrence After Neoadjuvant Therapy and Esophagectomy for Locally Advanced ESCC

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Despite improved interventions with radical esophagectomy accompanied by perioperative systematic therapy, recurrence remains frequent in locally advanced esophageal squamous cell carcinoma (ESCC). A clinically important subset experiences early recurr...

F. Su, Subinuer Maimaiti, Xu Huang et al. · 0 citations
Open access Aug 2026

PD01.03. Impact of Surgical Timing on Survival by Pathological Response Status in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy is standard treatment for esophageal squamous cell carcinoma (ESCC). Optimal surgical timing after nCRT remains unclear. Patients achieving pathological complete response (pCR) may demonstr...

Xu Huang, Fangyi Liu, Zitao Jian et al. · 0 citations
Aug 2026

P1.082. Neoadjuvant Chemoradiotherapy-to-Surgery Interval and Survival Stratified by Pathological Response in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, the optimal interval between nCRT completion and surgery remains undetermined, particularly rega...

Xu Huang, Fangyi Liu, Han Tang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.